A critical function of toll-like receptor-3 in the induction of anti-human immunodeficiency virus activities in macrophages

Immunology

Volumn 131, Issue 1, 2010, Pages 40-49

  Zhou, Yu ^a,b   Wang, Xu ^b   Liu, Manqing ^a   Hu, Quan ^a   Song, Li ^b   Ye, Li ^b   Zhou, Dunjin ^a   Ho, Wenzhe ^b  

^a Wuhan Centres for Disease Prevention and Control   (China)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CC chemokine; microRNA; poly I:C; tetherin; type I interferon

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; BETA CHEMOKINE; CELL PROTEIN; INTERFERON; MICRORNA; MICRORNA 125B; MICRORNA 150; MICRORNA 223; MICRORNA 28; MICRORNA 382; POLYINOSINIC POLYCYTIDYLIC ACID; TETHERIN; TOLL LIKE RECEPTOR 3; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INNATE IMMUNITY; MACROPHAGE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; VIRUS REPLICATION;

ANTIGENS, CD; ANTIVIRAL AGENTS; CHEMOKINES, CC; CYTIDINE DEAMINASE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, INNATE; INTERFERON TYPE I; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICRORNAS; POLY I-C; RNA, DOUBLE-STRANDED; TOLL-LIKE RECEPTOR 3; VIRUS REPLICATION;

EID: 77955136134     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2010.03270.x     Document Type: Article

References (47)

1. Deeks SG, Walker BD. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 2007 27 : 406 416.
2. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005 5 : 953 964.
3. Stout RD, Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol 2004 76 : 509 513.
4. Wang FX, Huang J, Zhang H, Ma X, Zhang H. APOBEC3G upregulation by alpha interferon restricts human immunodeficiency virus type 1 infection in human peripheral plasmacytoid dendritic cells. J Gen Virol 2008 89 : 722 730.
5. Adalid-Peralta L, Godot V, Colin C et al. Stimulation of the primary anti-HIV antibody response by IFN-alpha in patients with acute HIV-1 infection. J Leukoc Biol 2008 83 : 1060 1067.
6. Janeway CA Jr., Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002 20 : 197 216.
7. Delneste Y, Beauvillain C, Jeannin P. Innate immunity: structure and function of TLRs. Med Sci (Paris) 2007 23 : 67 73.
8. Hasko G, Pacher P, Deitch EA, Vizi ES. Shaping of monocyte and macrophage function by adenosine receptors. Pharmacol Ther 2007 113 : 264 275.
9. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006 124 : 783 801.
10. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997 388 : 394 397.
11. Kabelitz D, Medzhitov R. Innate immunity - cross-talk with adaptive immunity through pattern recognition receptors and cytokines. Curr Opin Immunol 2007 19 : 1 3.
12. Lauw FN, Caffrey DR, Golenbock DT. Of mice and man: TLR11 (finally) finds profilin. Trends Immunol 2005 26 : 509 511.
13. Lafon M, Megret F, Lafage M, Prehaud C. The innate immune facet of brain: human neurons express TLR-3 and sense viral dsRNA. J Mol Neurosci 2006 29 : 185 194.
14. Jackson AC, Rossiter JP, Lafon M. Expression of Toll-like receptor 3 in the human cerebellar cortex in rabies, herpes simplex encephalitis, and other neurological diseases. J Neurovirol 2006 12 : 229 234.
15. Trapp S, Derby NR, Singer R et al. Double-stranded RNA analog poly(I:C) inhibits human immunodeficiency virus amplification in dendritic cells via type I interferon-mediated activation of APOBEC3G. J Virol 2009 83 : 884 895.
16. Wang YJ, Wang X, Zhang H et al. Expression and regulation of antiviral protein APOBEC3G in human neuronal cells. J Neuroimmunol 2009 206 : 14 21.
17. Abrahams VM, Schaefer TM, Fahey JV et al. Expression and secretion of antiviral factors by trophoblast cells following stimulation by the TLR-3 agonist, Poly(I : C). Hum Reprod 2006 21 : 2432 2439.
18. Zhou Y, Ye L, Wan Q et al. Activation of Toll-like receptors inhibits herpes simplex virus-1 infection of human neuronal cells. J Neurosci Res 2009 87 : 2916 2925.
19. Daffis S, Samuel MA, Suthar MS, Gale M Jr., Diamond MS. Toll-like receptor 3 has a protective role against West Nile virus infection. J Virol 2008 82 : 10349 10358.
20. Broering R, Wu J, Meng Z et al. Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication. J Hepatol 2008 48 : 914 922.
21. Lau YF, Tang LH, Ooi EE. A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic. Vaccine 2009 27 : 1354 1364.
22. Berger EA, Doms RW, Fenyo EM et al. A new classification for HIV-1. Nature 1998 391 : 240.
23. Willey RL, Smith DH, Lasky LA, Theodore TS, Earl PL, Moss B, Capon DJ, Martin MA. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol 1988 62 : 139 147.
24. Guo CJ, Douglas SD, Gao Z, Wolf BA, Grinspan J, Lai JP, Riedel E, Ho WZ. Interleukin-1beta upregulates functional expression of neurokinin-1 receptor (NK-1R) via NF-kappaB in astrocytes. Glia 2004 48 : 259 266.
25. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004 4 : 499 511.
26. Alsharifi M, Mullbacher A, Regner M. Interferon type I responses in primary and secondary infections. Immunol Cell Biol 2008 86 : 239 245.
27. Cunningham S, Graham C, Hutchinson M et al. Pharmacogenomics of responsiveness to interferon IFN-beta treatment in multiple sclerosis: a genetic screen of 100 type I interferon-inducible genes. Clin Pharmacol Ther 2005 78 : 635 646.
28. Hamano E, Hijikata M, Itoyama S et al. Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population. Biochem Biophys Res Commun 2005 329 : 1234 1239.
29. + T lymphocytes. Nat Med 2007 13 : 1241 1247.
30. Wang X, Ye L, Hou W, Zhou Y, Wang YJ, Metzger DS, Ho WZ. Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood 2009 113 : 671 674.
31. Proost P, Schols D. Role of chemokines in the HIV infection process. Verh K Acad Geneeskd Belg 2002 64 : 403 420.
32. Kawai S, Azuma Y, Fujii E, Furugaki K, Ozaki S, Matsumoto T, Kosaka M, Yamada-Okabe H. Interferon-alpha enhances CD317 expression and the antitumor activity of anti-CD317 monoclonal antibody in renal cell carcinoma xenograft models. Cancer Sci 2008 99 : 2461 2466.
33. Neil SJ, Zang T, Bieniasz PD. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008 451 : 425 430.
34. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001 413 : 732 738.
35. Brule F., Marquet R., Rong L., Wainberg M.A., Roques B.P., Le Grice S.F., Ehresmann B., Ehresmann C. Structural and functional properties of the HIV-1 RNA-tRNA(Lys)3 primer complex annealed by the nucleocapsid protein: comparison with the heat-annealed complex. Rna 2002 8 : 8 15.
36. +-strand synthesis. J Mol Biol 1997 269 : 225 239.
37. Suh HS, Zhao ML, Rivieccio M et al. Astrocyte indoleamine 2,3-dioxygenase is induced by the TLR3 ligand poly(I:C): mechanism of induction and role in antiviral response. J Virol 2007 81 : 9838 9850.
38. Sheehy AM, Gaddis NC, Choi JD, Malim MH. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002 418 : 646 650.
39. Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 2003 424 : 99 103.
40. Mariani R, Chen D, Schrofelbauer B et al. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 2003 114 : 21 31.
41. Kumar A. The silent defense: micro-RNA directed defense against HIV-1 replication. Retrovirology 2007 4 : 26.
42. Ghosh Z, Mallick B, Chakrabarti J. Cellular versus viral microRNAs in host-virus interaction. Nucleic Acids Res 2009 37 : 1035 1048.
43. Lecellier CH, Dunoyer P, Arar K, Lehmann-Che J, Eyquem S, Himber C, Saib A, Voinnet O. A cellular microRNA mediates antiviral defense in human cells. Science 2005 308 : 557 560.
44. Hariharan M, Scaria V, Pillai B, Brahmachari SK. Targets for human encoded microRNAs in HIV genes. Biochem Biophys Res Commun 2005 337 : 1214 1218.
45. Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, Chisari FV, David M. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007 449 : 919 922. (Pubitemid 47598616)
46. Averett DR, Fletcher SP, Li W, Webber SE, Appleman JR. The pharmacology of endosomal TLR agonists in viral disease. Biochem Soc Trans 2007 35 : 1468 1472.
47. Kanzler H, Barrat FJ, Hessel EM, Coffman RL. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med 2007 13 : 552 559.